How to File a Leniency Application in the Czech Republic (UOHS), Immunity, Reduction, Markers & Evidence (2026)

Understanding how to file a leniency application with the Czech Office for the Protection of Competition (UOHS) can determine whether a company secures full immunity from cartel fines or merely a partial reduction. The Czech leniency programme, governed by Act No. 143/2001 Coll. on the Protection of Competition, rewards the first undertaking to disclose a cartel and cooperate fully with the regulator. Recent amendments affecting manager liability, marker procedures and reporting tools make the filing mechanics and strategic timing particularly important for compliance teams in 2026. This guide provides the step-by-step workflow, evidence checklists and tactical analysis that corporate counsel need to navigate the UOHS leniency process from marker request through to post-filing cooperation.

TL;DR, How to File a Leniency Application in 60 Seconds

• Who can apply. Any undertaking (or group of undertakings) that has participated in a cartel, including horizontal price-fixing, market-sharing or bid-rigging agreements, may submit a leniency application to UOHS.
• Where to file. Submit the application to UOHS via the dedicated leniency contact point published on the UOHS leniency programme page. Postal submissions to the UOHS headquarters in Brno serve as a backup channel.
• Marker first. Request a marker to secure a priority date in the leniency queue before compiling the full evidentiary package. The marker preserves first-in status while counsel gathers documents.
• Immunity vs reduction. The first qualifying applicant may receive full immunity from fines; subsequent cooperating applicants can obtain a fine reduction. Priority is determined by the order of qualifying applications received by UOHS.
• Evidence is decisive. Direct documentary evidence, emails, meeting minutes, call logs, carries the most weight. Compile and preserve evidence before or immediately after filing the marker.
• 2026 reforms matter. Recent amendments to Act No. 143/2001 Coll. have expanded manager liability provisions and refined the procedural tools available to UOHS, making early legal advice essential.

Quick Filing Checklist & Timeline

At-a-Glance Leniency Requirements

• Statutory basis. Act No. 143/2001 Coll. on the Protection of Competition (consolidated text).
• Regulator. UOHS, Úřad pro ochranu hospodářské soutěže, Brno.
• Filing channel. UOHS leniency contact point as published on the UOHS leniency programme page.
• Key condition. The applicant must provide information and evidence enabling UOHS to carry out a targeted inspection or otherwise prove the cartel infringement.
• Timing. Filing before UOHS has sufficient evidence to initiate proceedings is critical for immunity; later applicants may still qualify for a reduction.

UOHS Leniency Framework, Act No. 143/2001 Coll. and 2026 Reforms

The Czech leniency programme sits within the broader enforcement framework established by Act No. 143/2001 Coll. on the Protection of Competition. UOHS administers the programme and publishes procedural guidance on its dedicated leniency programme page. The programme is modelled on the European Commission’s leniency framework, meaning practitioners familiar with EU practice will recognise the core concepts, first-in priority, marker systems and graduated reductions, while needing to account for Czech-specific procedural details and statutory language.

Key Legal Definitions

• Cartel. Under the Act, a cartel is an agreement between competitors (horizontal agreement) that has as its object or effect the restriction of competition, including price-fixing, output limitation, market allocation and bid-rigging.
• Undertaking. Any entity engaged in economic activity, regardless of legal form. This includes parent companies and subsidiaries forming a single economic unit.
• Concerted practice. Coordination between undertakings that falls short of a formal agreement but substitutes practical cooperation for the risks of competition.

2026 Reform Highlights Affecting Leniency

Amendments to Act No. 143/2001 Coll., as reported in OECD enforcement reviews covering Czech competition policy, have introduced several changes directly relevant to how to file a leniency application in the Czech Republic:

• Manager liability. The reforms broadened the personal liability exposure of managers and directors involved in cartel conduct, creating stronger individual incentives to cooperate with UOHS through the leniency programme.
• Procedural tools. UOHS gained refined investigative tools, and the amendments clarified aspects of the marker system and confidential-information handling during leniency proceedings.
• Alignment with EU practice. The reforms moved Czech procedures closer to the European Commission’s model, including aspects of evidence handling and cross-border coordination via the European Competition Network (ECN).

Who Can Apply & Eligibility Conditions

Any undertaking that has participated in a cartel may submit a leniency application to UOHS. This includes individual companies, corporate groups (where the parent and subsidiaries form a single economic unit) and, under the 2026 framework, natural persons connected to the infringing undertaking may also benefit from leniency protections where they cooperate alongside the applicant entity.

The core eligibility conditions under the UOHS leniency programme require that the applicant:

• Provides UOHS with information and evidence that is sufficient to enable the authority to carry out a targeted inspection or to prove the infringement.
• Cooperates genuinely, fully and on a continuous basis throughout the proceedings.
• Has not coerced other undertakings to participate in the cartel (coercion typically disqualifies an applicant from full immunity).
• Terminates its involvement in the cartel no later than the time of the application (unless UOHS directs otherwise to preserve the integrity of an investigation).

Third-Party Applications

Customers, competitors or other third parties who are not cartel participants cannot file a leniency application for themselves, but they can submit complaints or information to UOHS that may trigger an investigation. The leniency programme is reserved for cartel participants seeking to mitigate their own liability through self-reporting and cooperation.

Leniency Marker System, Obtaining, Protecting and Converting a Marker

The leniency marker system is one of the most strategically important elements of how to file a leniency application in the Czech Republic. A marker secures the applicant’s place in the priority queue, critically, the first-in position that may lead to full immunity, while providing time to compile the complete evidentiary package.

When an undertaking contacts UOHS with a marker request, it provides minimum identifying information about the cartel (the product or service affected, the identity of participants, the nature of the anticompetitive conduct and the geographic scope). UOHS then confirms receipt of the marker and assigns a priority date. This date determines the applicant’s ranking relative to any other applicants for the same cartel.

The applicant must convert the marker into a full application within the protection window confirmed by UOHS. Failing to convert in time risks losing priority and, with it, the prospect of immunity.

Minimum Marker Information

A marker submission should include, at minimum:

• Applicant identity. Name and details of the applying undertaking (anonymous preliminary approaches may be possible, see below).
• Cartel description. The product or service affected, geographic scope and estimated duration of the infringement.
• Participants. Identities (or sufficient identifying details) of the other cartel participants.
• Nature of conduct. Whether the agreement involves price-fixing, market allocation, output restriction, bid-rigging or a combination.
• Evidence available. A brief description of the evidence the applicant expects to submit with the full application.

Risks of the Marker: Incomplete Information and Losing Priority

A marker does not guarantee immunity. If the information provided is too vague for UOHS to identify the cartel, the marker may not be accepted. Equally, if the applicant fails to convert the marker into a substantive application within the agreed timeframe, UOHS may release the priority date. Industry observers expect that under current UOHS practice, applicants who maintain open communication with the authority and demonstrate genuine progress in evidence gathering are more likely to receive reasonable extensions, but this is not guaranteed and should not be relied upon as a planning assumption.

Competition Leniency Evidence, What to Collect and Which Evidence Carries Most Weight

The strength of the evidence accompanying a leniency application is often the decisive factor in whether UOHS grants immunity or a reduction. Applicants should prioritise collecting direct documentary evidence before or immediately after filing the marker, as delays risk destruction, alteration or loss of critical materials.

Evidence Checklist

Formatting, Chain of Custody & Redaction Guidance

Evidence submitted to UOHS should be organised systematically to maximise its usefulness and preserve admissibility:

• File naming. Use a consistent convention: [Date]_[DocumentType]_[Description] (e.g., 2024-03-15_Email_PriceDiscussionCompetitorX).
• Chain of custody. Maintain a log recording when each document was collected, by whom, from which device or system and any handling steps. This is essential if UOHS or a court later challenges authenticity.
• Redactions. Redact only genuinely privileged material (legal advice privilege) and clearly mark each redaction with the basis claimed. Over-redaction risks undermining the application’s credibility.
• Digital integrity. Preserve original metadata. Do not edit, re-save or convert native-format files unless a clean copy is also submitted. Forensic imaging of devices is advisable where emails or messages are central to the case.

Using Forensic Data and Preserving Privilege

Engaging digital forensics specialists early, ideally before or at the same time as the marker, helps preserve volatile evidence such as deleted emails, messaging-app data and metadata that may no longer be available after routine IT processes run. Counsel should oversee all forensic collections to ensure that legally privileged communications are identified and separated before any material is submitted to UOHS. The ICN guidance on confidential information handling during cartel proceedings provides a comparative framework for managing business secrets and privilege claims during leniency submissions.

Cartel Immunity vs Reduction in the Czech Republic, Legal Tests and Tactical Calculus

The distinction between immunity and reduction is the central strategic question when deciding how to file a leniency application. Under the UOHS programme, consistent with the framework in Act No. 143/2001 Coll., the outcomes operate on a tiered basis linked to priority.

Immunity (first-in applicant). The first undertaking to provide UOHS with sufficient evidence, either enabling a targeted inspection that UOHS could not otherwise have conducted, or proving an infringement that UOHS could not otherwise have proved, may receive complete immunity from fines. This is subject to meeting all cooperation and eligibility conditions.

Reduction (subsequent applicants). Undertakings that apply after the first qualifying applicant but still provide significant added value to the investigation may receive a reduction in their fine. The level of reduction typically decreases with each successive applicant. Early indications from UOHS enforcement practice suggest that second-in applicants generally receive the largest reductions, with diminishing benefits for later cooperators.

When Immunity Is Unavailable, Partial Reduction Triggers

Immunity is unavailable when another undertaking has already secured the first-in position, or when the applicant coerced others to join the cartel. In those situations, the applicant should still consider applying for a reduction, as the fine mitigation can be substantial and cooperation itself may influence UOHS’s approach to related enforcement actions.

Tactical Decision Tree

• Scenario 1: First mover. File a marker immediately, convert to full application with the strongest available evidence, and cooperate fully, target immunity.
• Scenario 2: Uncertain timing. Submit a marker to secure a priority date, then gather further evidence and legal advice before committing to a full application. Speed is critical, every day of delay increases the risk of losing first-in position.
• Scenario 3: Already under investigation. If UOHS has commenced proceedings, full immunity may no longer be available, but substantial cooperation can still yield a significant fine reduction. Engage counsel immediately to assess the best remaining options.

Step-by-Step Filing Workflow, How to File a Leniency Application (Practical How-To)

The following numbered workflow reflects the procedural steps for filing a leniency application with UOHS, drawn from the UOHS leniency programme page and the statutory framework under Act No. 143/2001 Coll.:

1. Engage external competition counsel. Before any contact with UOHS, retain counsel experienced in Czech competition enforcement. Legal privilege must be managed from the outset.
2. Conduct preliminary internal assessment. Identify the scope of the infringement, the participants, the affected product/service and the approximate duration. This assessment informs the marker and the evidence-collection strategy.
3. Secure board or management approval. Internal approvals are needed for the decision to self-report, for cooperation commitments and for evidence preservation measures (including litigation holds).
4. Decide between anonymous preliminary approach and identified filing. UOHS may accept anonymous preliminary contacts in certain circumstances; however, converting to a full application typically requires identification. Counsel can manage confidentiality through preliminary discussions with the authority.
5. Prepare and submit the marker. Send the minimum marker information (applicant identity, cartel description, participants, nature of conduct, evidence summary) to the UOHS leniency contact point. Retain a postal backup submission for evidentiary certainty of the filing date.
6. Preserve evidence immediately. Issue litigation holds across the organisation. Engage forensic IT specialists to image relevant devices, preserve email archives and secure messaging data. Separate privileged materials under counsel’s supervision.
7. Compile the full evidentiary package. Organise evidence by type and priority (see the evidence checklist above). Prepare witness statements with counsel.
8. Convert the marker to a full leniency application. Submit the complete application, including a cover letter, narrative description of the infringement and all supporting evidence, within the marker protection window confirmed by UOHS.
9. Submit confidentiality requests. Identify any business secrets or commercially sensitive information and submit a reasoned confidentiality claim alongside the application.
10. Cooperate with UOHS requests. Respond promptly to follow-up document requests, agree to employee interviews and provide additional clarifications as needed. Continuous, genuine cooperation is a condition of maintaining leniency eligibility.
11. Prepare for interviews. Work with counsel to prepare employees who may be interviewed by UOHS. Ensure they understand the scope of cooperation obligations and the boundaries of privilege.
12. Implement post-filing compliance measures. Terminate cartel participation (if not already done), implement or strengthen competition compliance programmes and document remedial steps taken.

Cover letter checklist. The cover letter accompanying the full application should confirm: the applicant’s identity and contact details; a reference to the marker and its priority date; confirmation that cartel participation has ceased; a summary of the evidence submitted; any confidentiality claims; and a statement of the applicant’s commitment to ongoing cooperation.

Manager Liability, Privilege and Confidentiality, 2026 Updates and Practical Precautions

The 2026 amendments to Act No. 143/2001 Coll. have heightened the personal-liability exposure of managers and directors involved in cartel conduct. Industry observers expect this change to accelerate leniency filings, as individuals now face stronger personal incentives to encourage their organisations to self-report before competitors do.

Practical precautions for managing privilege and confidentiality during the leniency process include:

• Legal advice privilege. Communications between the applicant and its external lawyers for the purpose of seeking or giving legal advice are privileged. Internal investigation reports prepared under counsel’s direction should be clearly marked as privileged from creation.
• Employee interviews. Conduct interviews under counsel’s supervision. Inform employees of their rights, the purpose of the interview and the leniency requirements before recording any statement.
• Waiver risk. Submitting documents to UOHS does not, by itself, waive privilege over related communications. However, careless document handling, such as submitting privileged materials without a clear confidentiality claim, could undermine protections.
• Confidential treatment. UOHS procedures, consistent with ICN guidance on confidential information handling, allow applicants to request confidential treatment for business secrets. Applicants should submit a non-confidential version of their application alongside the confidential version.

After Filing, UOHS Procedure, Withdrawal Risks & Continuing Cooperation

Once UOHS receives a full leniency application, the authority will review the evidence, may request additional documents or clarifications and will typically conduct interviews with relevant employees. The applicant’s cooperation must remain genuine and continuous throughout the investigation. Partial disclosure, where an applicant withholds material information, risks disqualification from the programme entirely.

The formal decision on immunity or reduction is typically made as part of the final infringement decision. Until that decision is issued, the applicant’s leniency status remains provisional, and the obligation to cooperate continues.

When to Withdraw, and Its Consequences

Withdrawal of a leniency application is rare and carries significant risks. Information already disclosed to UOHS cannot be “un-disclosed,” and UOHS may use information obtained during the leniency process in its ongoing investigation. The likely practical effect of withdrawal is that the applicant loses any leniency benefit while UOHS retains investigative leads. Withdrawal should only be considered after careful legal analysis and is almost never advisable once a full application has been submitted.

Conclusion

Knowing how to file a leniency application with UOHS, from securing a marker through to full cooperation, is essential for any undertaking seeking to minimise cartel exposure in the Czech Republic. The 2026 reforms have raised the stakes for both companies and their managers. Early, well-prepared action remains the single most important factor in securing immunity rather than a reduction.

Last reviewed: July 27, 2026

Sources

1. Office for the Protection of Competition (UOHS), Leniency Programme
2. UOHS, Act on the Protection of Competition (Act No. 143/2001 Coll., consolidated text)
3. European Commission, Leniency Programme
4. WIPO Wipolex, Consolidated Act No. 143/2001 Coll.
5. OECD, Czech Republic Competition Enforcement Report
6. International Competition Network (ICN), CAP Template (Czech Republic)